Product
TRPV6 Calcium Channel Inhibitor SOR-C13
1 clinical trial
15 indications
Indication
Malignant NeoplasmIndication
Malignant Solid NeoplasmIndication
Ovarian CancerIndication
Pancreatic CancerIndication
Stage IIA Pancreatic Cancer AJCC v8Indication
Stage IIB Pancreatic Cancer AJCC v8Indication
Stage III Ovarian Cancer AJCC v8Indication
Stage III Pancreatic CancerIndication
Prostate Cancer, Stage III AJCC v8Indication
Prostate CancerIndication
Ovarian Cancer, Stage IIIB (AJCC v8)Indication
Prostate Cancer Stage IIIB AJCC v8Indication
Stage IV Ovarian CancerIndication
Stage IV Ovarian Cancer AJCC v8Indication
Ovarian Cancer Stage IVB AJCC v8Clinical trial
A Phase I Study of SOR-C13 in Patients With Advanced Solid TumorsStatus: Completed, Estimated PCD: 2023-06-20